戻る Agenda
Using Emerging Technologies and Electronic Data Sources for Conducting Trials
Session Chair(s)
Andrew Thomson, PhD, MA, MS
Statistician, Methodology Taskforce
European Medicines Agency, Netherlands
The session will feature presentations outlining key considerations to take into account when deciding on how and when to utilize emerging technologies in clinical development. The challenges and solutions will be illustrated with a case study.
Learning Objective : Outline the main challenges when deciding on whether and how to use emerging technologies in clinical trials Explain the principles for selecting and validating an endpoint in a clinical development programme based on emerging technologies Identify regulatory principles for ensuring successful clinical trials using emerging technologies
Speaker(s)
Title to be Announced
Robert Hemmings, MSc
Critical Path Institute, Netherlands
Using Emerging Technologies and Electronic Data Sources for Conducting Trials
Amy Cramer, BSN, MS, RN
Pfizer Inc, United States
Global Product Development Strategic Partnerships
Title to be Announced
Cécile Mathilde Ollivier, MS
Critical Path Institute, Netherlands
VP Global Affairs